You are here: All Products  > GenFleet Reports KRAS G12C Inhibitor is Under Review in China for NSCLC Approval

GenFleet Reports KRAS G12C Inhibitor is Under Review in China for NSCLC Approval

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products